1Raj GV, Moreno JG, Gomella LG. Utilization of polymerase chain reaction technology in the detection of solid tumors[J]. Cancer, 1998,82(8) : 1419-1442.
2Cote RJ, Rosen PP, Hakes TB, et al. Monoclorml antibody detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease[J]. Am J Surg Pathol, 1988,12(5) :333-340.
3Rostagno P, Moll JL, Bisconte JC, et al. Detection of rare circulating Breast Cancer cells by filtration cytometry and identification by DNA content: sensitivity in an experimental model IJ]. Anticancer Res,1997,17(4A) :2481-2485.
4Leers MPG, Schoffelen R, Hoop JGM, et al. Muhiparameter flow cytometry as a tool for the detection of micmmetastatic of tumor cells in the sentinel lymph node procedure of patients with breast cancer [ J]. J Clin Pathol, 2002,55 ( 5 ) : 359-366.
5West M, Blanchette C, Dressman H, et al. Predicting the clinical status of human breast cancer by using gene expression profiles[J]. Prec Natl Acad Sci,2001,98(20) : 11462-11467.
6van't Veer I j, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer [ J ]. Nature, 2002, 415(6871 ) : 530-536.
7Baker M, Gillanders WE, Mikhitarian K, et al. The molecular detection of micrometastatic breast cancer[J]. Am J Surgery,2003,186(4) :351-358.
8Bostick PJ, Chatterjee S, Chi DD, et al. limitations of specific reversetranscfiptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients [J]. J Clin Oecol, 1998,16(8) :2632-2640.
9Raynor M, Stephenson SA, Walsh DC, et al. Optimisation of the RTPCR detection of immunomagnetically enriched carcinoma cells [ J ].BMC Cancer,2002,2(1) :14.
10Hardingham JE, Hewett PJ, Sage RE, et al. Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease [ J ]. Int J Cancer. 2000.89 ( 1 ) : 8-13.
二级参考文献10
1Sawada T,Sakurada M,Hasegawa Y,et al.Intraoperative evaluation of axillary lymph nodes for micrometastases using immunohistochemistry-preliminary study.Rinsho Byori,2003,51(6):522-527.
2Marchetti A,Buttitta F,Bertacca G,et al.mRNA markers of breast cancer nodal metastases:comparision between mammaglobin and carcinoembryonic antigen in 248 patients.J Pathol,2001,195(2):186-190.
3Umekita Y,Ohi Y,Sagara Y,et al.Clinical significance of occult micrometastases in axillary lymph nodes in "node-negative" breast cancer patients.Jpn J Cancer Res,2002,93(6) :695-698.
4Pendas S,Dauway E,Cox CE,et al.Sentinal node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.Am Surg,1999,65(6):500-505.
5Choi SH,Barsky SH,Chang HR.Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.Breast J,2003,9(3):153-162.
6Slade MJ,Smith BM,Sinnett HD,et al.Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer.J Clin Oncol,1999,17(3):870-879.
7Ooka M,Tamaki Y,Sakita I,et al.Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer.Breast Cancer Res Treast,2001,67(2):169-175.
8Janni W,Gastroph S,Hepp F,et al.Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma.Cancer,2000,88(10):2252-2259.
9Braun S,Pantel K,Muller P,et al.Cytokeratin-positive cells in the bone marrow and survival of patients with stage Ⅰ ,Ⅱ,or Ⅲ breast cancer.N Engl J Med,2000,342(8) :525-533.
